Read all the latest news on 3Sixty Biopharmaceuticals
3SixtyBiopharma has signed an exclusive distribution agreement for the distribution of air purification systems in Africa. Airocide, originally developed by NASA has the potential to combat airborne pathogens & could be key in the fight against covid-19, as positive cases rise.
Not only do people have to deal with their own anxiety, stress and frustration, they also have to contend with the stigma attached to infertility. The Infertility Awareness Association of South Africa is hosting a number of webinars to mark National Infertility Awareness Week. Walter Mbatha from 3Sixty Biomedicine has more on this.
Applied UV and 3Sixty Biopharmaceuticals Sign Exclusive Distribution Agreement for Airocide(R) Air Purification Systems for the Continent of Africa
$3.5 million minimum first year purchase commitment of Airocide® systems MOUNT VERNON, NY / ACCESSWIRE / May 19, 2021 / Applied UV, Inc. (NASDAQ:AUVI) ("Applied UV" or the "Company"), an infection control technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, today announced the signing of an exclusive distribution...